<< Back

Richard S. Kollender
Richard has served as a member of our board of directors since March 2015. He currently serves as chief business officer, chief financial officer and as a member of the board of directors of Rapid Micro BioSystems. Since 2005, he has served as a partner of Quaker Partners Management, LP, a healthcare investment firm, which he initially joined in 2003. Richard is also on the board of directors of Tarsa Therapeutics. Richard also serves on the public policy committee for Pennsylvania Bio and is an adjunct faculty member at Lehigh University. He previously served on the board of directors of Insmed; Transave, Inc.; Nupathe, Inc.; TargetRx, Inc.; Precision Therapeutics, Inc.; Transport Pharmaceuticals, Inc.; Corridor Pharmaceuticals; Celator Pharmaceuticals; and PACT (Greater Philadelphia Alliance for Capital and Technologies). Richard has held positions in sales, marketing and worldwide business development at GlaxoSmithKline and served as investment manager at S.R. One. He practiced as a certified public accountant for 6 years at public accounting firms, including KPMG.

Richard holds an MBA with honors and a Certificate Degree in the Graduate Program in Health Administration and Policy from University of Chicago and a BA in accounting from Franklin and Marshall College.
Financial Expert

    © 2019 Strongbridge Biopharma plc
    STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Dublin Limited and Strongbridge U.S. Inc.
    KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
    MLR-0010 V15 01/2019

    • Ireland Address:
      Suite 206, Fitzwilliam Hall
      Fitzwilliam Place, Dublin 2, D02 T292
    • U.S. Address:
      900 Northbrook Drive, Suite 200
      Trevose, PA 19053
      United States

    Phone: +1 610-254-9200
    [email protected]

    Privacy Statement
    Compliance Program